about
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinomaAdaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens.Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations.T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies.CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.Effects of Physical Exercise on Markers of Cellular Immunosenescence: A Systematic Review.Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity.Measuring the immune system: a comprehensive approach for the analysis of immune functions in humans.Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15.Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites.Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group.Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.
P2860
Q33646189-45A19495-8907-400C-8C60-B37ECE04517DQ33733725-F9C0EDC0-B110-45F5-904E-838EBC6D82F6Q37513048-A1E65528-4596-4C4D-AC26-5AFAF7B8341CQ37541443-DFD8DA92-5062-4DD6-87A2-3CD1F9593810Q37639755-FA129FF6-91C3-4A71-A29E-0926CCCE0426Q38741001-46985C35-2FB9-4668-850C-0ED4CE01E457Q38963370-16D957E2-00B5-4A99-A14B-8EAD8792DB94Q39014514-BD8E1C6D-7E81-43CB-A34D-3E4BB2EFA9F0Q40071474-03FDAD96-A14D-4BDC-BB21-13DD3890B8F7Q40576699-B9D9CBD9-7FA0-48B5-BF85-488406F1F030Q41051473-A09D2B86-2BB7-4D98-A99E-73F0FA751DC0Q42380040-D4F74584-C3E4-4830-87EE-B78069D1042EQ47166524-51DD9889-4BEF-4F86-B1B5-7D351A928AEBQ47743446-281870D8-A00C-462A-B8AE-ABFC53122910Q47804698-6B8B24D2-AF9B-49A7-8DF8-AD6D359BF130Q55223108-D90702D5-C771-4D0C-813F-B0DE8B9CA4BEQ55514827-23A41D96-2D1F-4637-9F92-C1E335D4538B
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CD57 in human natural killer cells and T-lymphocytes.
@en
type
label
CD57 in human natural killer cells and T-lymphocytes.
@en
prefLabel
CD57 in human natural killer cells and T-lymphocytes.
@en
P2093
P2860
P1476
CD57 in human natural killer cells and T-lymphocytes.
@en
P2093
Anis Larbi
Hassen Kared
Serena Martelli
Sylvia L F Pender
Tze Pin Ng
P2860
P2888
P304
P356
10.1007/S00262-016-1803-Z
P577
2016-02-05T00:00:00Z
P6179
1046360906